Hospira Recalls Fentanyl Vials Due to Sterility Risk
Hospira recalls 47,400 vials of Fentanyl Citrate Injection due to loose or missing crimps that compromise sterility. Check lot numbers immediately.
Stop using this now
Lack of Assurance of Sterility: Fliptop vial crimps are loose or missing.
Contact the company
What happened, in plain English
Hospira Inc. is recalling 47,400 single-dose Fliptop Vials of Fentanyl Citrate Injection because the vial crimps may be loose or missing. This defect raises a lack of assurance of sterility, meaning the medication could be contaminated. The recall affects specific lots distributed nationwide. Read more at govinfonow.com/recall/45973-hospira-inc-recalls-fentanyl-citrate-injection-usp-2500-mcg-fentanyl.
Source Summary by GovInfoNow · govinfonow.com/recall/45973-hospira-inc-recalls-fentanyl-citrate-injection-usp-2500-mcg-fentanyl · Updated October 12, 2026 · FDA enforcement record: FDA #D-1433-201
Cite this page
“Hospira Recalls Fentanyl Vials Due to Sterility Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45973-hospira-inc-recalls-fentanyl-citrate-injection-usp-2500-mcg-fentanyl. Based on FDA recall #D-1433-201 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1433-201%22&limit=1).
Why it’s dangerous
The loose or missing crimps on the Fliptop vials can allow contaminants to enter the vial, compromising the sterility of the injection. Using a non-sterile injectable drug can lead to serious infections or other complications for the patient.
Who’s affected
Healthcare facilities and pharmacies in the U.S. that received this specific lot of Fentanyl Citrate Injection are affected. Patients receiving this medication from these sources are at risk if the product was used.
How to tell if you have this one
Look for Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL (50 mcg/mL) in 50 mL Single-dose Fliptop Vials. Check for NDC 0409-9094-61 and Lot #39474DK with an expiry date of 03/01/2016.
- Brand
Hospira- Category
Drug
What to do — step by step
Check Inventory
Verify if you have vials matching NDC 0409-9094-61 and Lot #39474DK.
Stop Use Immediately
Do not use or administer any vials from the recalled lot due to sterility risks.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1433-201 (June 27, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1433-201 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.